{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:09:03Z","timestamp":1790611743430,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP13307016"],"award-info":[{"award-number":["JP13307016"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL068200"],"award-info":[{"award-number":["R01 HL068200"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG074971"],"award-info":[{"award-number":["R01 AG074971"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Equol is an isoflavone (ISF)-derived metabolite by the gut microbiome in certain individuals termed equol-producers (EP). Equol might be the critical anti-atherogenic component of ISFs. In a population-based study of 979 Japanese men aged 40\u201379 without cardiovascular (CVD) or chronic kidney disease, we measured the urinary levels of equol and ISFs. Aortic calcification (AC) in the entire aorta was assessed by electron-beam or multi-detector-row computed tomography. Subjects with log10 (urinary equol to daidzein concentration)\u2009&gt;\u2009\u2212\u00a01.5 were classified as EP. EP was further classified as person with low- and high-equol. We analyzed the association between equol-producing status and AC presence, defined as AC score\u2009&gt;\u20090, by the logistic regressions. We found that EP (50% of the sample) had significantly lower odds of AC presence (odds ratio (OR): 0.62, 95% confidence interval (CI): 0.39, 0.98) compared to non-EP. This association was independent of CVD risk factors. For the dose\u2013response association, compared to non-EP, subjects with low and high levels of equol had ORs of 0.51 (95% CI 0.30, 0.84) and 0.67 (95% CI 0.39, 1.14) after adjusting for major CVD risk factors (<jats:italic>p<\/jats:italic> for trend\u2009=\u20090.06). ISFs concentrations were not significantly associated with AC presence (OR: 1.18, 95% CI: 0.82, 1.69). In conclusion, EP had a significantly lower burden of AC than non-EP, while ISFs were not associated with AC presence in Japanese men aged 40\u201379\u00a0years.<\/jats:p>","DOI":"10.1038\/s41598-022-24659-8","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T09:11:02Z","timestamp":1669194662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cross-sectional association of equol producing status with aortic calcification in Japanese men aged 40\u201379\u00a0years"],"prefix":"10.1038","volume":"12","author":[{"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fujiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuki","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barinas-Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sekikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"24659_CR1","doi-asserted-by":"publisher","first-page":"1192S","DOI":"10.3945\/jn.110.121830","volume":"140","author":"MA Klein","year":"2010","unstructured":"Klein, M. A. et al. Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J. Nutr. 140, 1192S-1204S (2010).","journal-title":"J. Nutr."},{"key":"24659_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.jea.7500429","volume":"15","author":"L Valentin-Blasini","year":"2005","unstructured":"Valentin-Blasini, L. et al. Urinary phytoestrogen concentrations in the U.S. population (1999\u20132000). J. Expo Anal. Environ. Epidemiol. 15, 509\u2013523. https:\/\/doi.org\/10.1038\/sj.jea.7500429 (2005).","journal-title":"J. Expo Anal. Environ. Epidemiol."},{"key":"24659_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12199-013-0338-6","volume":"18","author":"W Liu","year":"2013","unstructured":"Liu, W., Tanabe, M., Harada, K. H. & Koizumi, A. Levels of urinary isoflavones and lignan polyphenols in Japanese women. Environ. Health Prev. Med. 18, 394\u2013400. https:\/\/doi.org\/10.1007\/s12199-013-0338-6 (2013).","journal-title":"Environ. Health Prev. Med."},{"key":"24659_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/mnfr.200600262","volume":"51","author":"JP Yuan","year":"2007","unstructured":"Yuan, J. P., Wang, J. H. & Liu, X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora\u2013implications for health. Mol. Nutr. Food Res. 51, 765\u2013781 (2007).","journal-title":"Mol. Nutr. Food Res."},{"key":"24659_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/nu11092231","volume":"11","author":"B Mayo","year":"2019","unstructured":"Mayo, B., V\u00e1zquez, L. & Fl\u00f3rez, A. B. Equol: A bacterial metabolite from the daidzein isoflavone and its presumed beneficial health effects. Nutrients 11, 2231 (2019).","journal-title":"Nutrients"},{"key":"24659_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/ije\/dys130","volume":"41","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Urinary isoflavonoids and risk of coronary heart disease. Int. J. Epidemiol. 41, 1367\u20131375 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"24659_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.106.683755","volume":"116","author":"Y Kokubo","year":"2007","unstructured":"Kokubo, Y. et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations. Circulation 116, 553\u20132562 (2007).","journal-title":"Circulation"},{"key":"24659_CR8","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/STROKEAHA.111.620831","volume":"42","author":"HN Hodis","year":"2011","unstructured":"Hodis, H. N. et al. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: A randomized controlled trial. Stroke 42, 3168\u20133175 (2011).","journal-title":"Stroke"},{"key":"24659_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1573403X15666181205104717","volume":"15","author":"A Sekikawa","year":"2019","unstructured":"Sekikawa, A. et al. Effect of S-equol and soy isoflavones on heart and brain. Curr. Cardiol. Rev. 15, 114\u2013135 (2019).","journal-title":"Curr. Cardiol. Rev."},{"key":"24659_CR10","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1093\/jn\/132.12.3577","volume":"132","author":"KD Setchell","year":"2002","unstructured":"Setchell, K. D., Brown, N. M. & Lydeking-Olsen, E. The clinical importance of the metabolite equol\u2014A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132, 3577\u20133584 (2002).","journal-title":"J. Nutr."},{"key":"24659_CR11","doi-asserted-by":"publisher","first-page":"fnab082","DOI":"10.1093\/femsle\/fnab082","volume":"368","author":"L V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez, L., Fl\u00f3rez, A. B., Rodr\u00edguez, J. & Mayo, B. Heterologous expression of equol biosynthesis genes from Adlercreutzia equolifaciens. FEMS Microbiol. Lett. 368, fnab082 (2021).","journal-title":"FEMS Microbiol. Lett."},{"key":"24659_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000335049","volume":"21","author":"Y Shimada","year":"2011","unstructured":"Shimada, Y. et al. Identification of two novel reductases involved in equol biosynthesis in Lactococcus strain 20\u201392. Microb. Physiol. 21, 160\u2013172 (2011).","journal-title":"Microb. Physiol."},{"key":"24659_CR13","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1128\/AEM.03693-12","volume":"79","author":"C Schr\u00f6der","year":"2013","unstructured":"Schr\u00f6der, C., Matthies, A., Engst, W., Blaut, M. & Braune, A. Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl. Environ. Microbiol. 79, 3494\u20133502 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"24659_CR14","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.2174\/092986707782360178","volume":"14","author":"KA Jackman","year":"2007","unstructured":"Jackman, K. A., Woodman, O. L. & Sobey, C. G. Isoflavones, equol and cardiovascular disease: Pharmacological and therapeutic insights. Curr. Med. Chem. 14, 2824\u20132830 (2007).","journal-title":"Curr. Med. Chem."},{"key":"24659_CR15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","volume":"66","author":"RL McClelland","year":"2015","unstructured":"McClelland, R. L. et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J. Am. Coll. Cardiol. 66, 1643\u20131653 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"24659_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ehjci\/jey173","volume":"20","author":"H K\u00e4lsch","year":"2019","unstructured":"K\u00e4lsch, H. et al. Association of progressive thoracic aortic calcification with future cardiovascular events and all-cause mortality: Ability to improve risk prediction? Results of the Heinz Nixdorf Recall (HNR) study. Eur. Heart J.-Cardiovasc. Imaging 20, 709\u2013717 (2019).","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"24659_CR17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/ATVBAHA.114.303268","volume":"34","author":"MH Criqui","year":"2014","unstructured":"Criqui, M. H. et al. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34, 1574\u20131579 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"24659_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2010.11.017","volume":"215","author":"MJ Budoff","year":"2011","unstructured":"Budoff, M. J. et al. Thoracic aortic calcification and coronary heart disease events: The multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 215, 196\u2013202 (2011).","journal-title":"Atherosclerosis"},{"key":"24659_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijcard.2022.01.065","volume":"352","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Association of equol producing status with aortic calcification in middle-aged Japanese men: The ERA JUMP study. Int. J. Cardiol.\u00a0352, 158\u2013164 (2022).","journal-title":"Int. J. Cardiol."},{"key":"24659_CR20","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.3390\/nu13113739","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Potential protective effects of equol (soy isoflavone metabolite) on coronary heart diseases\u2014from molecular mechanisms to studies in humans. Nutrients 13, 3739 (2021).","journal-title":"Nutrients"},{"key":"24659_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1017\/S000711451600458X","volume":"117","author":"V Ahuja","year":"2017","unstructured":"Ahuja, V. et al. Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men. Br. J. Nutr. 117, 260\u2013266 (2017).","journal-title":"Br. J. Nutr."},{"key":"24659_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3945\/ajcn.112.043745","volume":"97","author":"PJ Curtis","year":"2013","unstructured":"Curtis, P. J. et al. Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: A double-blind randomized controlled trial. Am. Clin. Nutr. 97, 936\u2013942 (2013).","journal-title":"Am. Clin. Nutr."},{"key":"24659_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mnfr.201300499","volume":"58","author":"Z-M Liu","year":"2014","unstructured":"Liu, Z.-M. et al. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: A 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. Mol. Nutr. Food Res. 58, 709\u2013717 (2014).","journal-title":"Mol. Nutr. Food Res."},{"key":"24659_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2265.2012.04400.x","volume":"78","author":"T Usui","year":"2013","unstructured":"Usui, T. et al. Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin. Endocrinol. 78, 365\u2013372 (2013).","journal-title":"Clin. Endocrinol."},{"key":"24659_CR25","doi-asserted-by":"publisher","first-page":"1386S","DOI":"10.3945\/jn.109.118307","volume":"140","author":"T Aso","year":"2010","unstructured":"Aso, T. Equol improves menopausal symptoms in Japanese women. J. Nutr. 140, 1386S-1389S. https:\/\/doi.org\/10.3945\/jn.109.118307 (2010).","journal-title":"J. Nutr."},{"key":"24659_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/gme.0b013e31818379fa","volume":"16","author":"N Ishiwata","year":"2009","unstructured":"Ishiwata, N., Melby, M. K., Mizuno, S. & Watanabe, S. New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women. Menopause 16, 141\u2013148 (2009).","journal-title":"Menopause"},{"key":"24659_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/jwh.2011.3153","volume":"21","author":"BH Jenks","year":"2012","unstructured":"Jenks, B. H. et al. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency. J. Womens Health 21, 674\u2013682. https:\/\/doi.org\/10.1089\/jwh.2011.3153 (2012).","journal-title":"J. Womens Health"},{"key":"24659_CR28","doi-asserted-by":"publisher","first-page":"e12089","DOI":"10.1002\/trc2.12089","volume":"6","author":"A Sekikawa","year":"2020","unstructured":"Sekikawa, A. et al. Associations of equol-producing status with white matter lesion and amyloid-\u03b2 deposition in cognitively normal elderly Japanese. Alzheimers Dement. 6, e12089. https:\/\/doi.org\/10.1002\/trc2.12089 (2020).","journal-title":"Alzheimers Dement."},{"key":"24659_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1099\/ijs.0.65404-0","volume":"58","author":"T Maruo","year":"2008","unstructured":"Maruo, T., Sakamoto, M., Ito, C., Toda, T. & Benno, Y. Adlercreutzia equolifaciens gen. nov., sp. Nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int. J. Syst. Evol. Microbiol. 58, 1221\u20131227 (2008).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"24659_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1099\/ijs.0.016774-0","volume":"60","author":"J-S Jin","year":"2010","unstructured":"Jin, J.-S., Kitahara, M., Sakamoto, M., Hattori, M. & Benno, Y. Slackia equolifaciens sp. Nov., a human intestinal bacterium capable of producing equol. Int. J. Syst. Evol. Microbiol. 60, 1721\u20131724 (2010).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"24659_CR31","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1128\/AEM.00555-08","volume":"74","author":"A Matthies","year":"2008","unstructured":"Matthies, A. et al. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl. Environ. Microbiol. 74, 4847\u20134852 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"24659_CR32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/ije\/dyv143","volume":"44","author":"A Sekikawa","year":"2015","unstructured":"Sekikawa, A. et al. Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study. Int. J. Epidemiol. 44, 1614\u20131624 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"24659_CR33","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","volume":"118","author":"H Ueshima","year":"2008","unstructured":"Ueshima, H. et al. Cardiovascular disease and risk factors in Asia: A selected review. Circulation 118, 2702\u20132709 (2008).","journal-title":"Circulation"},{"key":"24659_CR34","doi-asserted-by":"publisher","first-page":"e003144","DOI":"10.1161\/JAHA.115.003144","volume":"5","author":"U Hoffmann","year":"2016","unstructured":"Hoffmann, U. et al. Cardiovascular event prediction and risk reclassification by coronary, aortic, and valvular calcification in the Framingham Heart Study. J. Am. Heart Assoc. 5, e003144 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"24659_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-018-1124-x","volume":"19","author":"H-C Chen","year":"2018","unstructured":"Chen, H.-C. et al. Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients: A 5-year prospective cohort study. BMC Nephrol. 19, 1\u20137 (2018).","journal-title":"BMC Nephrol."},{"key":"24659_CR36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/01.CIR.0000120708.59903.1B","volume":"109","author":"IM Van Der Meer","year":"2004","unstructured":"Van Der Meer, I. M. et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: The Rotterdam Study. Circulation 109, 1089\u20131094 (2004).","journal-title":"Circulation"},{"key":"24659_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjcard.2007.08.032","volume":"101","author":"YS Levitzky","year":"2008","unstructured":"Levitzky, Y. S. et al. Prediction of intermittent claudication, ischemic stroke, and other cardiovascular disease by detection of abdominal aortic calcific deposits by plain lumbar radiographs. Am. J. Cardiol. 101, 326\u2013331 (2008).","journal-title":"Am. J. Cardiol."},{"key":"24659_CR38","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/ATVBAHA.110.208181","volume":"30","author":"MH Criqui","year":"2010","unstructured":"Criqui, M. H. et al. Risk factor differences for aortic versus coronary calcified atherosclerosis: The multiethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 2289\u20132296 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"24659_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2015.12.027","volume":"246","author":"H Ueshima","year":"2016","unstructured":"Ueshima, H. et al. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population. Atherosclerosis 246, 141\u2013147 (2016).","journal-title":"Atherosclerosis"},{"key":"24659_CR40","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/ndt\/gfv100","volume":"30","author":"GD Group","year":"2015","unstructured":"Group, G. D. et al. Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR< 45 mL\/min). Nephrol. Dial. Transplant. 30, ii1\u2013ii142 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"24659_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.jhh.1001627","volume":"18","author":"T Okamura","year":"2004","unstructured":"Okamura, T. et al. Specific alcoholic beverage and blood pressure in a middle-aged Japanese population: The High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. J. Hum. Hypertens. 18, 9\u201316 (2004).","journal-title":"J. Hum. Hypertens."},{"key":"24659_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1467-789X.2006.00292.x","volume":"8","author":"APCS Collaboration","year":"2007","unstructured":"Collaboration, A. P. C. S. The burden of overweight and obesity in the Asia-Pacific region. Obes. Rev. 8, 191\u2013196 (2007).","journal-title":"Obes. Rev."},{"key":"24659_CR43","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJM199506013322207","volume":"332","author":"RJ Havel","year":"1995","unstructured":"Havel, R. J. & Rapaport, E. Management of primary hyperlipidemia. N. Engl. J. Med. 332, 1491\u20131498 (1995).","journal-title":"N. Engl. J. Med."},{"key":"24659_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13340-012-0069-8","volume":"3","author":"A Kashiwagi","year":"2012","unstructured":"Kashiwagi, A. et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol. Int. 3, 8\u201310 (2012).","journal-title":"Diabetol. Int."},{"key":"24659_CR45","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41430-018-0242-7","volume":"73","author":"A Sekikawa","year":"2019","unstructured":"Sekikawa, A. et al. Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men. Eur. J. Clin. Nutr. 73, 783\u2013792 (2019).","journal-title":"Eur. J. Clin. Nutr."},{"key":"24659_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2188\/jea.JE20180258","volume":"30","author":"A Fujiyoshi","year":"2020","unstructured":"Fujiyoshi, A. et al. Proteinuria and reduced estimated glomerular filtration rate are independently associated with lower cognitive abilities in apparently healthy community-dwelling elderly men in Japan: A cross-sectional study. J. Epidemiol. 30, 244\u2013252 (2020).","journal-title":"J. Epidemiol."},{"key":"24659_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio, M., Imai, E., Yasuda, Y., Watanabe, T. & Matsuo, S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: Accuracy and use for population estimates. Am. J. Kidney Dis. 56, 32\u201338 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"24659_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fct.2016.05.021","volume":"95","author":"SC Fleck","year":"2016","unstructured":"Fleck, S. C., Churchwell, M. I., Doerge, D. R. & Teeguarden, J. G. Urine and serum biomonitoring of exposure to environmental estrogens II: Soy isoflavones and zearalenone in pregnant women. Food Chem. Toxicol. 95, 19\u201327 (2016).","journal-title":"Food Chem. Toxicol."},{"key":"24659_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.5551\/jat.44784","volume":"26","author":"C Kimani","year":"2019","unstructured":"Kimani, C. et al. Differences between coronary artery calcification and aortic artery calcification in relation to cardiovascular disease risk factors in Japanese men. J. Atheroscler. Thromb.\u00a026, 452\u2013464 (2019).","journal-title":"J. Atheroscler. Thromb."},{"key":"24659_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston, A. S. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15, 827\u2013832 (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"24659_CR51","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1093\/jn\/136.8.2188","volume":"136","author":"KD Setchell","year":"2006","unstructured":"Setchell, K. D. & Cole, S. J. Method of defining equol-producer status and its frequency among vegetarians. J. Nutr. 136, 2188\u20132193 (2006).","journal-title":"J. Nutr."},{"key":"24659_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10554-012-0051-3","volume":"29","author":"H K\u00e4lsch","year":"2013","unstructured":"K\u00e4lsch, H. et al. Prevalence of thoracic aortic calcification and its relationship to cardiovascular risk factors and coronary calcification in an unselected population-based cohort: The Heinz Nixdorf Recall Study. Int. J. Cardiovasc. Imaging 29, 207\u2013216 (2013).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"24659_CR53","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1210\/jc.2012-3426","volume":"98","author":"CB Confavreux","year":"2013","unstructured":"Confavreux, C. B. et al. Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. J. Clin. Endocrinol. Metab. 98, 1084\u20131092 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24659_CR54","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.107.705202","volume":"116","author":"NI Parikh","year":"2007","unstructured":"Parikh, N. I. et al. Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts. Circulation 116, 1473\u20131481 (2007).","journal-title":"Circulation"},{"key":"24659_CR55","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jama.290.7.891","volume":"290","author":"P Greenland","year":"2003","unstructured":"Greenland, P. et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290, 891\u2013897 (2003).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24659-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:02:11Z","timestamp":1669230131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24659-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20114"}}